Companies /Healthcare

Amarin Corp

NASDAQ: AMRN Drug Manufacturers - General
$12.75
▲ $0.80 (+6.65%) today
Markets closed · 10:37pm ET

AMRN Coverage Page 3

10:00am ET
Health and Healthcare

Why Amarin Shares Are Exploding

Amarin shares absolutely skyrocketed on Monday after the company announced topline results from the Vascepa cardiovascular (CV) outcomes trial, REDUCE-IT. Needless to say, the results were very positive.

Chris Lange
11:50am ET
Health and Healthcare

Amarin Reaches Settlement Terms With FDA

Amarin made some headway in Wednesday's regular trading session following a settlement with the U.S. Food and Drug Administration.

Chris Lange